Patents by Inventor Maria Mycielska

Maria Mycielska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200408741
    Abstract: The present invention is directed to a method for the diagnosis of cancer involving the plasma membrane citrate transporter (pmCiC). The invention is further directed to a modified substrate or modulator of pmCiC, the use of pmCiC as a tumor marker and a method of screening for a modulator of pmCiC activity.
    Type: Application
    Filed: August 26, 2020
    Publication date: December 31, 2020
    Inventors: Edward Geissler, Maria Mycielska, Petra Rümmele
  • Patent number: 10768167
    Abstract: The present invention is directed to a method for the diagnosis of cancer involving the plasma membrane citrate transporter (pmCiC). The invention is further directed to a modified substrate or modulator of pmCiC, the use of pmCiC as a tumor marker and a method of screening for a modulator of pmCiC activity.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: September 8, 2020
    Assignee: Universitätsklinikum Regensburg
    Inventors: Edward Geissler, Maria Mycielska, Petra Rümmele
  • Publication number: 20170241981
    Abstract: The present invention is directed to a method for the diagnosis of cancer involving the plasma membrane citrate transporter (pmCiC). The invention is further directed to a modified substrate or modulator of pmCiC, the use of pmCiC as a tumor marker and a method of screening for a modulator of pmCiC activity.
    Type: Application
    Filed: September 25, 2015
    Publication date: August 24, 2017
    Inventors: Edward Geissler, Maria Mycielska, Petra Rümmele